Uzbekistan Brings Together the International Community at the UN to Strengthen the Fight Against Childhood Cancer
29.9.2025 10:59:00 CEST | Business Wire | Press Release
For the first time in the history of the United Nations General Assembly, Uzbekistan held a special event dedicated to “A global movement to improve survival and reduce suffering for children with cancer and other catastrophic diseases”.
The event was hosted by the Government of Uzbekistan, WHO, St. Jude Children’s Research Hospital and Zamin Foundation.
The event was attended by the First Ladies of Azerbaijan, Angola, Vietnam, Guatemala, Serbia, and Türkiye, the spouse of the Prime Minister of Lebanon, the Director-General of WHO, the President of ECOSOC, the President and leadership of St. Jude Children’s Research Hospital, as well as the Ministers of Health of Angola, Armenia, Bangladesh, Mozambique, the Dominican Republic, Nigeria, Kazakhstan, Qatar, the Republic of the Congo, Kyrgyzstan, Malta, Mongolia, the UAE, Peru, Tajikistan, Timor-Leste, Tuvalu, Türkiye, Chad, and Jamaica, along with representatives of healthcare authorities of Hungary, Indonesia, Russia and Tanzania, international organizations, experts and civil society representatives.
The event showcased the results of the Global Initiative for Childhood Cancer and the Global Platform for Access to Childhood Cancer Medicines. Participants reaffirmed their commitment to achieving a 60% survival rate for children with cancer by 2030 through the development of equitable, integrated and locally resourced health systems.
In her address to the participants of the event, chair of the Board of Trustees of the Zamin Foundation Ziroat Mirziyoyeva mentioned:
"Currently, more than 2 billion children worldwide are at risk or suffer from non-communicable diseases. That is almost a third of the world's population. Millions of them are fighting cancer. Despite the achievements of modern medicine, survival rates remain uneven: in developed countries, they are above 80%, while in developing countries, they are below 30%. This is an unacceptable gap. We are obliged to take steps in order to prevent this tragedy!"
In his address, Director-General of the World Health Organization Dr. Tedros Adhanom Ghebreyesus underlined emphasized: “Every child suffering from cancer deserves an equal right to fight for their life, regardless of the country or community they come from. That is why we launched the WHO Global Initiative for Childhood Cancer. The results speak for themselves: the program has helped more than 400 thousand children in 80 low- and middle-income countries”.
Speaking at the event, St. Jude Children’s Research Hospital President James R. Downing stated: “To fulfill our promise that no child should die at the dawn of life, we are laying the foundations of the Global Sickle Cell Disease Initiative, aimed at improving survival rates among children with this condition. I call on every United Nations member state to join both global initiatives. This must become a priority for all countries”.
Children affected by these diseases became special guests of the event. Their touching stories deeply resonated with the participants. From Uzbekistan, young graduate and volunteer of Mehrli maktab, Samira Idrisova, shared her journey.
Uzbekistan is actively contributing to the global movement for children’s health. In recent years, the country has implemented large-scale programs to reduce child cancer mortality, mobilized additional resources, introduced new standards for diagnosis and treatment, and expanded access to medicines.
The country has adopted the National Strategy to Combat Childhood Cancer for 2025–2030, aligned with the WHO’s CureAll framework. The strategy envisions raising the early detection rate to 65%, increasing one-year survival from 34% to 90%, five-year survival to 60%, and ensuring 100% access to specialized multidisciplinary care.
Moreover, an International Academic Hub for Childhood Cancer has been established in Tashkent aimed at facilitating the integration of international standards in diagnostics, specialist training, and innovation, as well as the exchange of best practices and the development of modern clinical research.
The event became an important international platform for the exchange of expertise, demonstration of solidarity and promotion of innovative solutions in addressing one of the most pressing and often underestimated challenges in global healthcare.
The discussion continued with panel sessions focused on sustaining progress in childhood cancer treatment and implementing the global initiative to combat sickle cell anemia.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250926977972/en/
Contacts
For more information, please contact:
Elena Ikaeva
Director of the Department on media and public relations, IPF Zamin
Phone: +998 712052525
+998 935645050
E-mail: e.ikaeva@zaminfoundation.ngo
https://zaminfoundation.ngo/en/about -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fzaminfoundatio
n.ngo%2Fen%2Fabout&esheet=54330372&newsitemid=20250926977972&lan=en-US&anchor=ht
tps%3A%2F%2Fzaminfoundation.ngo%2Fen%2Fabout&index=1&md5=3977c661221018741b0cade
6f464b7f3
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Verdant Rock Receives A (low) Financial Strength Rating from Morningstar DBRS, Adding a Second International Investment-Grade Assessment9.10.2026 16:00:00 CEST | Press Release
Verdant Rock Limited, a Bermuda Monetary Authority-regulated Class 3B insurance company, has received an A (low) Financial Strength Rating from Morningstar DBRS. The rating reflects Verdant Rock’s financial strength and its capacity to meet policyholder obligations as an investment-grade financial guarantor for Emerging Markets credit. Morningstar DBRS is a global credit rating agency with coverage across North America, Europe, Asia, and Latin America. Its assessment of Verdant Rock reflects the company’s strong projected earnings ability, robust risk profile, sound liquidity, and good capitalization. Morningstar DBRS also assigned an A (low) Issuer Rating to Verdant Rock. The rating follows Verdant Rock’s BBB+ Long-Term Insurer Financial Strength Rating with a Stable Outlook from Fitch Ratings, assigned on 12 June 2026. Verdant Rock now holds Financial Strength Ratings from both Fitch Ratings and Morningstar DBRS, providing counterparties with dual-agency confirmation of the company’s
Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions9.10.2026 15:17:00 CEST | Press Release
Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, today announced that Gartner has positioned it as a Visionary in the first-ever Magic Quadrant for AI-Enabled CSP Marketing and Sales Solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261009905430/en/ Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions A new category for a new operating model. CSPs are fighting saturated markets, rising acquisition costs, and accelerating churn. They are responding with AI-driven automation across the full revenue cycle, from segmentation and campaigns to lead management, CPQ, and renewals, increasingly executed by autonomous agents. According to us, Gartner creation of this Magic Quadrant confirms the shift has moved from pilot to boardroom priority. According to Gartner, Visionaries "understands where the market
Positive New Data on Corcym’s Perceval Plus Sutureless Aortic Heart Valve Encompasses up to 7-Year Follow-up9.10.2026 15:15:00 CEST | Press Release
Corcym, a global medical device company dedicated to cardiac surgery, today announced that positive mid-term data from a sub-analysis of its Perceval Plus sutureless aortic heart valve as part of its MANTRA clinical trial was featured in an oral presentation today at the annual meeting of the European Association for Cardio-Thoracic Surgery (EACTS). The study is the longest follow-up available for Perceval Plus and the FREE tissue treatment from an international multicenter study, and demonstrated excellent durability, safety and quality of life improvements. Perceval Plus is the only sutureless and collapsible aortic surgical heart valve. Its unique design performs in any surgical scenario and is optimal for endoscopy and robotics. The valve features the company’s FREE next generation tissue treatment addressing the two main causes of calcification, phospholipids and aldehydes. Its proprietary LANCELOT advanced manufacturing process includes zero-pressure shaping and laser cutting of
Ada earns AWS Travel and Hospitality Competency for resolving traveler issues at scale9.10.2026 15:00:00 CEST | Press Release
Ada, the pioneer in Agentic Customer Experience, today announced it has achieved the Amazon Web Services (AWS) Travel and Hospitality Competency. The designation recognizes Ada as an AWS Partner with demonstrated technical proficiency and proven customer success helping travel and hospitality brands resolve customer issues at scale. Ada joins a select group of 58 AWS Partners holding the competency, and it reflects a shared commitment to helping travel brands deliver service that holds up on their busiest, most unpredictable days. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261009673638/en/ Ada earns AWS Travel and Hospitality Competency for resolving traveler issues at scale "Travel is where agentic customer service gets tested hardest. Demand spikes without warning, policies change by the hour, and customers are often stressed and far from home," said Mike Murchison, CEO and co-founder of Ada. "Our airline and hospitali
Hitachi Joins Anthropic’s Critical Infrastructure Defense Program9.10.2026 02:32:00 CEST | Press Release
Hitachi, Ltd. (TSE:6501, "Hitachi"), today announced that it has joined Anthropic, PBC’s (“Anthropic”) “Critical Infrastructure Defense Program,” launched on October 8, 2026, as a founding partner. The program is aimed at strengthening cyber defense for critical infrastructure, including control systems supporting power, water, manufacturing, and transportation services. Infrastructure systems that underpin society and the economy cannot tolerate prolonged downtime, making it difficult to implement certain security measures, such as system shutdowns for patch deployment. At the same time, advances in AI are significantly shortening the time between vulnerability disclosure and exploitation, creating an urgent need to redesign systems based on the assumption that cyberattacks will occur. The program seeks to strengthen cybersecurity through rapid vulnerability detection and remediation by integrating Anthropic’s advanced AI models, Claude, into the products and services of trusted syste
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom